76 related articles for article (PubMed ID: 23930204)
1. Prognostic impact and the relevance of PTEN copy number alterations in patients with advanced colorectal cancer (CRC) receiving bevacizumab.
Price TJ; Hardingham JE; Lee CK; Townsend AR; Wrin JW; Wilson K; Weickhardt A; Simes RJ; Murone C; Tebbutt NC
Cancer Med; 2013 Jun; 2(3):277-85. PubMed ID: 23930204
[TBL] [Abstract][Full Text] [Related]
2. Cyclophilin A: An Independent Prognostic Factor for Survival in Patients with Metastatic Colorectal Cancer Treated with Bevacizumab and Chemotherapy.
Moisuc DC; Constantinescu D; Marinca MV; Gafton B; Pavel-Tanasa M; Cianga P
Cancers (Basel); 2024 Jan; 16(2):. PubMed ID: 38254874
[TBL] [Abstract][Full Text] [Related]
3. Correlation of extended RAS and PIK3CA gene mutation status with outcomes from the phase III AGITG MAX STUDY involving capecitabine alone or in combination with bevacizumab plus or minus mitomycin C in advanced colorectal cancer.
Price TJ; Bruhn MA; Lee CK; Hardingham JE; Townsend AR; Mann KP; Simes J; Weickhardt A; Wrin JW; Wilson K; Gebski V; Van Hazel G; Robinson B; Cunningham D; Tebbutt NC
Br J Cancer; 2015 Mar; 112(6):963-70. PubMed ID: 25742472
[TBL] [Abstract][Full Text] [Related]
4. The predictive value of KRAS, NRAS, BRAF, PIK3CA and PTEN for anti-EGFR treatment in metastatic colorectal cancer: A systematic review and meta-analysis.
Therkildsen C; Bergmann TK; Henrichsen-Schnack T; Ladelund S; Nilbert M
Acta Oncol; 2014 Jul; 53(7):852-64. PubMed ID: 24666267
[TBL] [Abstract][Full Text] [Related]
5. Carboplatin plus paclitaxel once a week versus every 3 weeks in patients with advanced ovarian cancer (MITO-7): a randomised, multicentre, open-label, phase 3 trial.
Pignata S; Scambia G; Katsaros D; Gallo C; Pujade-Lauraine E; De Placido S; Bologna A; Weber B; Raspagliesi F; Panici PB; Cormio G; Sorio R; Cavazzini MG; Ferrandina G; Breda E; Murgia V; Sacco C; Cinieri S; Salutari V; Ricci C; Pisano C; Greggi S; Lauria R; Lorusso D; Marchetti C; Selvaggi L; Signoriello S; Piccirillo MC; Di Maio M; Perrone F; ; ; ; ;
Lancet Oncol; 2014 Apr; 15(4):396-405. PubMed ID: 24582486
[TBL] [Abstract][Full Text] [Related]
6. Conformational stability and catalytic activity of PTEN variants linked to cancers and autism spectrum disorders.
Johnston SB; Raines RT
Biochemistry; 2015 Feb; 54(7):1576-82. PubMed ID: 25647146
[TBL] [Abstract][Full Text] [Related]
7. Predictive and prognostic biomarkers with therapeutic targets in advanced colorectal cancer.
Luo HY; Xu RH
World J Gastroenterol; 2014 Apr; 20(14):3858-74. PubMed ID: 24744578
[TBL] [Abstract][Full Text] [Related]
8. Copy Number Alterations as Novel Biomarkers and Therapeutic Targets in Colorectal Cancer.
Tan ES; Knepper TC; Wang X; Permuth JB; Wang L; Fleming JB; Xie H
Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565354
[TBL] [Abstract][Full Text] [Related]
9. Cell-Free DNA Detection of Tumor Mutations in Heterogeneous, Localized Prostate Cancer Via Targeted, Multiregion Sequencing.
Chen E; Cario CL; Leong L; Lopez K; Márquez CP; Li PS; Oropeza E; Tenggara I; Cowan J; Simko JP; Kageyama R; Wells DK; Chan JM; Friedlander T; Aggarwal R; Paris PL; Feng F; Carroll PR; Witte JS
JCO Precis Oncol; 2021; 5():. PubMed ID: 34250416
[TBL] [Abstract][Full Text] [Related]
10. PTEN in Colorectal Cancer: Shedding Light on Its Role as Predictor and Target.
Salvatore L; Calegari MA; Loupakis F; Fassan M; Di Stefano B; Bensi M; Bria E; Tortora G
Cancers (Basel); 2019 Nov; 11(11):. PubMed ID: 31717544
[TBL] [Abstract][Full Text] [Related]
11. Molecular characterization and biomarker identification in colorectal cancer: Toward realization of the precision medicine dream.
Goel G
Cancer Manag Res; 2018; 10():5895-5908. PubMed ID: 30510457
[TBL] [Abstract][Full Text] [Related]
12. Association of PTEN expression with biochemical recurrence in prostate cancer: results based on previous reports.
Xie H; Xie B; Liu C; Wang J; Xu Y
Onco Targets Ther; 2017; 10():5089-5097. PubMed ID: 29123407
[TBL] [Abstract][Full Text] [Related]
13. Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and American Society of Clinical Oncology.
Sepulveda AR; Hamilton SR; Allegra CJ; Grody W; Cushman-Vokoun AM; Funkhouser WK; Kopetz SE; Lieu C; Lindor NM; Minsky BD; Monzon FA; Sargent DJ; Singh VM; Willis J; Clark J; Colasacco C; Rumble RB; Temple-Smolkin R; Ventura CB; Nowak JA
J Mol Diagn; 2017 Mar; 19(2):187-225. PubMed ID: 28185757
[TBL] [Abstract][Full Text] [Related]
14. Molecular Biomarkers for the Evaluation of Colorectal Cancer.
Sepulveda AR; Hamilton SR; Allegra CJ; Grody W; Cushman-Vokoun AM; Funkhouser WK; Kopetz SE; Lieu C; Lindor NM; Minsky BD; Monzon FA; Sargent DJ; Singh VM; Willis J; Clark J; Colasacco C; Rumble RB; Temple-Smolkin R; Ventura CB; Nowak JA
Am J Clin Pathol; 2017 Mar; 147(3):221-260. PubMed ID: 28165529
[TBL] [Abstract][Full Text] [Related]
15. Somatic gene copy number alterations in colorectal cancer: new quest for cancer drivers and biomarkers.
Wang H; Liang L; Fang JY; Xu J
Oncogene; 2016 Apr; 35(16):2011-9. PubMed ID: 26257062
[TBL] [Abstract][Full Text] [Related]
16. A critical role of mir-199a in the cell biological behaviors of colorectal cancer.
Ye H; Pang L; Wu Q; Zhu Y; Guo C; Deng Y; Zheng X
Diagn Pathol; 2015 Jun; 10():65. PubMed ID: 26065676
[TBL] [Abstract][Full Text] [Related]
17. A comprehensive analysis of phosphatase and tensin homolog deleted on chromosome 10 (PTEN) loss in colorectal cancer.
Lin PC; Lin JK; Lin HH; Lan YT; Lin CC; Yang SH; Chen WS; Liang WY; Jiang JK; Chang SC
World J Surg Oncol; 2015 May; 13():186. PubMed ID: 25986931
[TBL] [Abstract][Full Text] [Related]
18. KRAS mutation influences recurrence patterns in patients undergoing hepatic resection of colorectal metastases.
Kemeny NE; Chou JF; Capanu M; Gewirtz AN; Cercek A; Kingham TP; Jarnagin WR; Fong YC; DeMatteo RP; Allen PJ; Shia J; Ang C; Vakiani E; D'Angelica MI
Cancer; 2014 Dec; 120(24):3965-71. PubMed ID: 25155157
[TBL] [Abstract][Full Text] [Related]
19. Palliative care and end-stage colorectal cancer management: the surgeon meets the oncologist.
Costi R; Leonardi F; Zanoni D; Violi V; Roncoroni L
World J Gastroenterol; 2014 Jun; 20(24):7602-21. PubMed ID: 24976699
[TBL] [Abstract][Full Text] [Related]
20. Can we accurately report PTEN status in advanced colorectal cancer?
Hocking C; Hardingham JE; Broadbridge V; Wrin J; Townsend AR; Tebbutt N; Cooper J; Ruszkiewicz A; Lee C; Price TJ
BMC Cancer; 2014 Feb; 14():128. PubMed ID: 24564252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
